NCT06466421 - Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 20, 2024

Conditions

Uremic PruritusChronic Kidney Disease-associated PruritusHemodialysisEnd-stage Renal DiseaseRenal Replacement TherapyESRD

Interventions

DRUG

Fexofenadine

Fexofenadine 60 mg orally once daily for 3 months

DRUG

Gabapentin

100 mg after each dialysis session (thrice weekly). Dose may be titrated after 2 weeks, according to response and tolerability, to 100 mg orally once daily for 3 months.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER